Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | XmAb819 |
Synonyms | |
Therapy Description |
XmAb819 is a bispecific antibody that targets ENPP3 and CD3, potentially resulting in increased T-cell response against tumor cells expressing ENPP3 (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
XmAb819 | XmAb 819|XmAb-819|XmAb30819 | CD3 Antibody 97 | XmAb819 is a bispecific antibody that targets ENPP3 and CD3, potentially resulting in increased T-cell response against tumor cells expressing ENPP3 (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05433142 | Phase I | XmAb819 | Study of XmAb819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma | Recruiting | USA | 0 |